Doximity, Inc.

NYSE:DOCS

Medical - Healthcare Information Services

Healthcare
$30.67 -0.44%

-$0.09 today

Market cap
$5.47B
Beta
1.29
P/E (TTM)
19.2
EPS (TTM)
$1.06
52W Low $17.15High $76.51

Volume 2.27M

Average 3.89M

DOCS EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Doximity, Inc.NYSE: DOCS

EBITDA · Q2 FY2027 · quarter ended Sep 2026

EBITDA declines year over year

Q2 FY2027 EBITDA of $43.92M fell 42.5% year over year, behind the -29.4% change in trailing-twelve-month EBITDA. Sequentially, it fell 1.6% from the prior quarter. Over 3 fiscal years it compounded at +22.6% a year.

Context

  • EBITDA amounted to 41.0% of revenue in FY2026, down 1.2 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 15 analysts of $310.42M (+17.4%) for the fiscal year ending Mar 2027, a step up from the +9.8% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$43.92M-1.6% QoQ
Last fiscal yearMar 2026
$264.39M+9.8% YoY
LTMSep 2026
$209.61M-29.4% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-42.5%+19.5%+62.0 pp
1 year+9.8%+17.4%+7.6 pp
3-year CAGR+22.6%+13.3%-9.3 pp
5-year CAGR+13.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2026
264.39M USD
Year-over-year change
+9.8%
4-year CAGR
+22.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How DOCS compares with its peers on the latest reported figures

  • DOCS's LTM Sep 2026 EBITDA of $209.61M is the 8th highest of the 10 companies compared; the peer median is $910.3M.
  • Its year-over-year change of -29.4% is the lowest of 10, against a peer median of -6.7%.
  • EBITDA amounts to 31.7% of revenue for DOCS, versus a peer median of 24.2%.
DOCS Competitors Peer median
EBITDA for DOCS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VTRSViatris Inc.LTM Jun 2026$2.72B +650.7%—18.4%
SOLVSolventum CorporationLTM Jun 2026$2.47B +93.4%+3.9%29.7%
EHCEncompass Health CorporationLTM Jun 2026$1.5B +14.8%+17.3%24.2%
ICLRICON Public Limited CompanyLTM Jun 2026$1.25B -9.3%-15.5%15.1%
COOThe Cooper Companies, Inc.LTM Jul 2026$910.3M -16.6%+6.2%21.5%
RVTYRevvity, Inc.LTM Jul 2026$767M -6.7%-13.5%26.3%
HQYHealthEquity, Inc.LTM Jul 2026$495.07M +22.1%+41.8%36.3%
DOCSDoximity, Inc.LTM Sep 2026$209.61M -29.4%+22.6%31.7%
TEMTempus AI, Inc.LTM Sep 2026-$108.97M -19.4%—7.2%
GHGuardant Health, Inc.LTM Sep 2026-$441.45M -24.7%—34.5%
Peer median (excluding DOCS) $910.3M-6.7%+5.1%24.2%

Competitors are the stored peer set for DOCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue343.55M419.05M475.42M570.4M644.86M
Cost of Revenue39.79M53.49M50.67M55.87M70.33M
Gross Profit303.76M365.56M424.75M514.53M574.54M
Gross Margin88.4%87.2%89.3%90.2%89.1%
Research & Development62.35M80.19M81.98M93.04M130.7M
Selling, General & Admin127.88M160.27M170.96M191.38M228.92M
Operating Expenses190.23M240.45M260.88M286.73M359.62M
Depreciation & Amortization5.04M10.28M10.27M10.66M14.38M
EBITDA119.05M143.44M182.08M240.76M264.39M
EBITDA Margin34.7%34.2%38.3%42.2%41.0%
Operating Income113.54M125.11M163.88M227.8M214.92M
Operating Margin33.0%29.9%34.5%39.9%33.3%
Interest Income2.15M9.29M21.66M35.85M35.7M
Interest Expense00000
Other Income / Expenses469K8.05M21.32M35.77M35.09M
Income Before Tax114.01M133.16M185.2M263.57M250.01M
Pre-Tax Margin33.2%31.8%39.0%46.2%38.8%
Income Tax Expense(40.78M)20.34M37.62M40.39M53.95M
Net Income154.78M112.82M147.58M223.19M196.05M
Net Margin45.1%26.9%31.0%39.1%30.4%
EPS (Basic)0.810.580.781.191.05
EPS (Diluted)0.700.530.721.110.98
Weighted Avg Shares163.48M193.18M190.17M186.84M187.01M
Weighted Avg Shares (Diluted)191.02M213.43M205.73M201.21M199.05M

Doximity, Inc.

NYSE:DOCS

Intrinsic Alpha fair value

Locked

Current Price

$30.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.